Stockreport

ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions

ADMA Biologics Inc  (ADMA) 
Last adma biologics inc earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.admabiologics.com
PDF RAMSEY, N.J. and BOCA RATON, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) is a vertically integrated biopharmaceutical and specialty immu [Read more]